|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investments in marketable securities | ||||||||||||||||||||
| Trade receivables, net | ||||||||||||||||||||
| TSA receivables, net | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid manufacturing | ||||||||||||||||||||
| Other prepaids and current assets | ||||||||||||||||||||
| Assets held for sale, current (Note 6) | ||||||||||||||||||||
| Assets of discontinued operations, current (Note 6) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Inventory, non-current | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets, non-current | ||||||||||||||||||||
| Assets held for sale, non-current (Note 6) | ||||||||||||||||||||
| Assets of discontinued operations, non-current (Note 6) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued rebates, fees and reserves | ||||||||||||||||||||
| TSA payables and other accrued liabilities | ||||||||||||||||||||
| TSA payables and accrued liabilities | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Accrued and other current liabilities | ||||||||||||||||||||
| Term loans, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Term loan, non-current | ||||||||||||||||||||
| Convertible notes, non-current | ||||||||||||||||||||
| Lease liabilities, non-current | ||||||||||||||||||||
| Other liabilities, non-current | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock ($0.0001 par value; shares authorized: 300,000,000; shares issued and outstanding: 154,470,363 and 121,154,925 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
